# Acarbose, Postprandial Hypotension and Type 2 Diabetes

> **NCT02043886** · PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 15 (actual)

## Conditions studied

- Type 2 Diabetes
- Postprandial Hypotension

## Interventions

- **DRUG:** Acarbose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02043886
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2013-01
- **Final completion:** 2014-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043886, "Acarbose, Postprandial Hypotension and Type 2 Diabetes". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02043886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*